Australia's Clinuvel Pharmaceuticals jumps 11% on higher FY24 profit
** Shares of Clinuvel Pharmaceuticals CUV.AX jump 11%, set
for best day since July 5
** Stock on track for its fifth day of consecutive gains
** Pharmaceutical co's FY24 profit jumps 16%, while gains
15%
** Maintains annual dividend of A$0.05 per share
** Stock cuts YTD losses to about 3%
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist